Technological watch
Sulzer’s bio-plastic technology selected for Yangzhou Huitong Biological New Material’s plant
Sulzer has been awarded by Yangzhou Huitong Biological New Material to supply technology and key equipment for its polylactic acid (PLA) production facility in Jiangsu Province, China. The facility will have a production capacity of 30’000 tonnes per year.
The plant will be able to produce a large portfolio of PLA grades serving a broad range of end-use applications from food packaging to kitchen utensils or toys. Replacing traditional plastics with non-fossil based plastics directly contributes to an improved carbon footprint.
The versatility of Sulzer’s PLA technology allows the production of a large range of molecular weights and stereoisomer ratios, while meeting product high-quality standards.
To meet Yangzhou Huitong Biological New Material’s requirements, Sulzer Chemtech will design and provide its lactide purification, polymerization, devolatilization and post-reaction proprietary technologies. The licensing agreement framework also includes extensive service support from engineering to technical assistance and field services. Sulzer Chemtech was selected for its proven track record as market leader, delivering scalable production solutions with both improved efficiency and quality for the production of PLA.
Zhang JianGang, President of Yangzhou Huitong Biological New Material, adds: “This new facility will allow us to enter the fast-growing bioplastic market. We consider Sulzer an extremely valuable partner in this project. The company’s comprehensive technical services and cutting-edge production technologies for PLA will help us to effectively produce sustainable plastics and meet our customers’ strategic demands.”
Torsten Wintergerste, Division President of Sulzer Chemtech, comments: “We are excited to support Yangzhou Huitong Biological New Material in their flagship project. Our PLA technologies are currently used in most PLA facilities worldwide. We couldn’t be prouder to be supporting customers with monomer purification and polymer production units that are helping advance the sustainable and circular plastics sector.”
The plant will be able to produce a large portfolio of PLA grades serving a broad range of end-use applications from food packaging to kitchen utensils or toys. Replacing traditional plastics with non-fossil based plastics directly contributes to an improved carbon footprint.
The versatility of Sulzer’s PLA technology allows the production of a large range of molecular weights and stereoisomer ratios, while meeting product high-quality standards.
To meet Yangzhou Huitong Biological New Material’s requirements, Sulzer Chemtech will design and provide its lactide purification, polymerization, devolatilization and post-reaction proprietary technologies. The licensing agreement framework also includes extensive service support from engineering to technical assistance and field services. Sulzer Chemtech was selected for its proven track record as market leader, delivering scalable production solutions with both improved efficiency and quality for the production of PLA.
Zhang JianGang, President of Yangzhou Huitong Biological New Material, adds: “This new facility will allow us to enter the fast-growing bioplastic market. We consider Sulzer an extremely valuable partner in this project. The company’s comprehensive technical services and cutting-edge production technologies for PLA will help us to effectively produce sustainable plastics and meet our customers’ strategic demands.”
Torsten Wintergerste, Division President of Sulzer Chemtech, comments: “We are excited to support Yangzhou Huitong Biological New Material in their flagship project. Our PLA technologies are currently used in most PLA facilities worldwide. We couldn’t be prouder to be supporting customers with monomer purification and polymer production units that are helping advance the sustainable and circular plastics sector.”
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 870292.
